Seer to Participate in the Piper Sandler Virtual Healthcare Conference
November 22, 2021 08:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company...
Seer Reports Third Quarter 2021 Financial Results
November 09, 2021 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer Appoints Rachel Haurwitz, Ph.D., to its Board of Directors
November 08, 2021 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed...
Seer to Report Third Quarter Financial Results on November 9, 2021
October 12, 2021 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
Seer to Present at the Morgan Stanley Global Healthcare Conference
September 02, 2021 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be...
Seer Reports Second Quarter 2021 Financial Results
August 12, 2021 16:06 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer Bio Partners with Enlight Medical to Commercialize the Proteograph™ Product Suite in China
August 12, 2021 16:01 ET
|
Seer, Inc.
REDWOOD CITY, Calif. and BEIJING, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has...
Seer to Report Second Quarter Financial Results on August 12, 2021
July 13, 2021 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., July 13, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
Seer Reports First Quarter 2021 Financial Results
May 10, 2021 16:05 ET
|
Seer, Inc.
Second Phase of Commercialization Advances with the Addition of Multiple Limited Release Customers REDWOOD CITY, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences...
Seer to Present at the BofA Securities 2021 Healthcare Conference
May 04, 2021 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be...